原发性和继发性玻璃体视网膜淋巴瘤的分子特征
该研究对31例VRL患者(原发16例、同步3例、继发12例)的34份玻璃体切除样本进行靶向测序,发现MYD88(74%)、PIM1(71%)、CD79B(55%)等高频突变及9p21/CDKN2A缺失(75%),与原发中枢神经系统淋巴瘤的MCD亚型相似;玻璃体液上清游离DNA可可靠检出这些突变。
要点
- VRL高频突变谱为MYD88、PIM1、CD79B、IGLL5、TBL1XR1、ETV6及CDKN2A缺失。
- 原发、同步与继发VRL的突变频率相似,支持其与PCNSL同源。
- 玻璃体液游离DNA可检测细胞DNA中的突变,有助无创诊断。
核心结论
- VRL与原发中枢神经系统淋巴瘤的MCD亚型分子特征相似,突变分析可用于诊断。
研究设计与样本
- 对31例VRL患者(原发16例、同步3例、继发12例)的34份玻璃体切除样本及葡萄膜炎阴性对照行靶向NGS。
- 部分病例使用OncoScan平台评估全基因组拷贝数变异。
主要发现
- MYD88突变74%、PIM1突变71%、CD79B突变55%、IGLL5突变52%、TBL1XR1突变48%、ETV6突变45%。
- 9p21/CDKN2A缺失占75%,原发、同步与继发VRL频率相似。
- OncoScan分析显示平均每例18.6个拷贝数变异。
- 阴性对照无突变或拷贝数变异。
临床怎么用
- 对玻璃体样本行突变分析可作为VRL的高灵敏度和特异度诊断工具。
- 玻璃体液上清游离DNA可可靠检出细胞DNA中的突变,适用于无细胞学诊断材料时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitreoretinal lymphoma (VRL) is a rare subtype of diffuse large B-cell lymphoma (DLBCL) considered a variant of primary central nervous system lymphoma (PCNSL). The diagnosis of VRL requires examination of vitreous fluid, but cytologic differentiation from uveitis remains difficult. Because of its rarity and the difficulty in obtaining diagnostic material, little is known about the genetic profile of VRL. The purpose of our study was to investigate the mutational profile of a large series of primary and secondary VRL. Targeted next-generation sequencing using a custom panel containing the most frequent mutations in PCNSL was performed on 34 vitrectomy samples from 31 patients with VRL and negative controls with uveitis. In a subset of cases, genome-wide copy number alterations (CNAs) were assessed using the OncoScan platform. Mutations in MYD88 (74%), PIM1 (71%), CD79B (55%), IGLL5 (52%), TBL1XR1 (48%), ETV6 (45%), and 9p21/CDKN2A deletions (75%) were the most common alterations, with similar frequencies in primary (n = 16), synchronous (n = 3), or secondary (n = 12) VRL. This mutational spectrum is similar to MYD88mut/CD79Bmut (MCD or cluster 5) DLBCL with activation of Toll-like and B-cell receptor pathways and CDKN2A loss, confirming their close relationship. OncoScan analysis demonstrated a high number of CNAs (mean 18.6 per case). Negative controls lacked mutations or CNAs. Using cell-free DNA of vitreous fluid supernatant, mutations present in cellular DNA were reliably detected in all cases examined. Mutational analysis is a highly sensitive and specific tool for the diagnosis of VRL and can also be applied successfully to cell-free DNA derived from the vitreous.
引用
- Bonzheim I, Sander P, Salmerón-Villalobos J, et al. The molecular hallmarks of primary and secondary vitreoretinal lymphoma. Blood Adv. 2022. PMID: 34448823. doi:10.1182/bloodadvances.2021004212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。